Sucroferric Oxyhydroxide
Composition
This formulation contain Sucroferric Oxyhydroxide as active agent
Indications
It is indicated for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Side effects
diarrhea, discolored feces (often dark in color due to iron content), and nausea
Precautions
should be used with caution in patients with iron metabolism disorders or a history of iron overload
Contraindications
It is contraindicated in patients with iron overload syndromes, such as hemochromatosis or hemosiderosis
Dosage and administration
directed by a healthcare professional
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai